Erinacines as cyathane-xylosides are known to have potent stimulating activity for nerve-growth-factor synthesis. Our search for new cyathane metabolites from a liquid culture of Hericium erinaceum YB4-6237 resulted in the isolation of a new erinacine named erinacine Q (1). NMR spectrometry and a chemical derivation from erinacine P (2) determined the compound to be a derivative in which the formyl group of erinacine P had been reduced to the hydroxymethyl group. 
Erinacines [1] [2] [3] [4] and striatins, 5) which are diterpenexylosides possessing a cyathane skeleton, are currently attracting attention because of their unique biological activities. Erinacines have potent stimulating activity for nerve-growth-factor synthesis [1] [2] [3] [4] and agonistic activity towards the k opioid receptor. 6) In particular, erinacine C (5) is known to the most potent stimulator of the erinacines for nerve-growthfactor synthesis. 1) In addition, striatins have leishmanicidal activity. 7) We have reported in a previous paper the isolation of new erinacine P (2) from the mycelia of Hericium erinaceum YB4-6237 and its in vitro biomimetic conversion into erinacine A (3) and B (4) (Fig. 1) . 8) Our search for new cyathane metabolites biosynthetically related to erinacines from this basidiomycete resulted in the isolation of a new cyathane-xyloside named erinacine Q (1) (Fig. 1 ) from the mycelial extract. From a biosynthetic point of view, 1 seems to be a precursor of 2 as a parental metabolite of 3, 4 and 5. We report here the isolation and structural elucidation of 1 from this basidiomycete, and its biotransformation into 5 via 2 by using [1?- 13 
Materials and Methods
General procedures. Optical rotation data were measured by a Horiba SEPA-300 digital polarimeter. 1 H-and 13 C-NMR spectra were recorded by a Jeol EX-400 spectrometer, and FABMS and HR-FABMS data were recorded by a JMS-700 mass spectrometer. Flash chromatography employed Wako FC-40 silica gel, and HPLC analysis was conducted with a Jasco PU-980 instrument equipped with a Jasco UV-970 detector.
Extraction and isolation. H. erinaceum YB4-6237 was reciprocally shake-cultured for 20 days at 259 C in 2000-ml Sakaguchi ‰asks, each containing 500 ml of a 5z D-glucose-0.5z peptone-1z Pharmamedia-0.5z NaCl medium. The fermentation broth (3 liter) wasˆltered to give mycelia (182 g by wet weight) and the cultureˆltrate. The mycelia were homogenized with acetone (900 ml), treated at 509 C for one hour and thenˆltered to give an aqueous acetone solution. This solution was concentrated under reduced pressure, and the resulting aqueous solution was extracted with n-hexane (450 ml) at pH 9, before the aqueous layer was extracted with EtOAc (450 ml). The EtOAc layer was washed with brine, dried over anhydrous Na2SO4, and concentrated under reduced pressure to give a dark brownish residue (6.6 g). This residue was separated by silica gel ‰ash chromatography, using mixtures of CHCl 3 HPLC analysis of the erinacines. Erinacines A, B and C were analyzed by HPLC under the following conditions: column, Crestpack C18S (150×4.6 mm i.d., Jasco); solvent, 40:10 CH3OH W H2O; ‰ow rate, 1.5 ml W min; detection, 210 nm. The retention times of erinacines A, B and C were 4.1, 6.1 and 6.7 min, respectively. Erinacines P and Q were analyzed by the similar conditions: column, Crestpack C18S (150 ×4.6 mm i.d., Jasco); solvent, 40:70 CH3CN W H2O; ‰ow rate, 2.5 ml W min; detector, 210 nm. The retention times of erinacines P and Q were 18.9 and 13.1 min, respectively.
Preparation of erinacine Q (1) from erinacine P (2). To an ice-cooled solution of 2 (11.1 mg, 0.0225 mmol) in MeOH (1 ml) was added excess NaBH4 (¿10 mg). The reaction mixture was stirred at 09 C for 20 min before adding aqueous 20z acetone (2.5 ml) and then extracted tree times with EtOAc (12 ml). The organic solution obtained was separated, washed with brine, dried over anhydrous Na2SO4, and concentrated under reduced pressure to give a residue. This residue was separated by silica gel ‰ash chromatography with a mixture of CHCl3 and EtOH C]-2). H. erinaceum YB4-6237 was reciprocally shake-cultured at 259 C in a 500-ml Sakaguchi ‰ask containing 100 ml of a 2z D-glucose-0.3z peptone-0.6z Pharmamedia-0.5z NaCl medium. [1- 13 C]-D-Glucose (0.5 g, 99 atomz 13 C, Sigma-Aldrich) was added 5 days after inoculation, and the culture was continued for a further 9 days. The fermentation broth (100 ml) wasˆltered to give mycelia (5.4 g by wet weight) and a residue (150 mg) in a similar manner to that already described. The residue was separated by silica gel ‰ash chromatography with mixtures of CHCl3 and EtOH (40:1-20:1) to yield 13 C-labeled 2 (9.0 mg). The intensity of the C-1? signal of [1?-13 C]-2 was strongly enriched in the 13 C-NMR spectrum ( Fig. 2(e) ). Fig. 2(b) .
Feeding experiments of [1?-13 C]erinacine Q ([1?-13 C]-1) to H. erinaceum YB4-6237. The basidiomycete was reciprocally shake-cultured at 259 C in a 100-ml Sakaguchi ‰ask containing 30 ml of a 2z D-glucose-0.2z peptone-0.4z Pharmamedia-0.2z NaCl medium. [1?-13 C]-1 (2.0 mg) was added 10 days after inoculation, and the culture was continued for a further 7 days. The fermentation broth (20 ml) wasˆltered to give mycelia (700 mg by wet weight) and a residue (20 mg) in a similar manner to that already described. This residue was separated by silica gel ‰ash chromatography with mixtures of CHCl 3 and EtOH (40:1-20:1) to yield erinacine P (0.7 mg) as a colorless amorphous solid. Its 1 H-and 13 C-NMR data were in good agreement with those for [1?-13 C]-2. The 13 C-NMR spectrum is shown in Fig. 2(c) .
Feeding experiments of [1?-13 C]erinacine P ([1?-13 C]-2) to H. erinaceum YB4-6237. The basidiomycete was reciprocally shake-cultured at 259 C in a 500-ml Sakaguchi ‰ask containing 100 ml of a 2z D-glucose-0.2z peptone-0.4z Pharmamedia-0.2z NaCl medium. [1?-13 C]-2 (4.0 mg), which had been prepared by feeding [1- 13 C]-D-glucose to the basidiomycete, was added 13 days after inoculation, and the culture was continued for a further 16 days. The fermentation broth (100 ml) wasˆltrated to give mycelia (1.9 g by wet weight) and a residue (230 mg) by a similar manner to that already described. This residue was separated by silica gel ‰ash chromatography with mixtures of CHCl3 and EtOH (40:1-20:1) to yield erinacine C as a colorless amorphous solid (1.3 mg) and [1?-13 C]-2 (1.6 mg). The 1 Hand 13 C-NMR data ( Fig. 2(f ) ) for the solid were in good agreement with those quoted in the literature.
1)

Results and Discussion
To elucidate the biosynthetic pathway to erinacines in H. erinaceum YB4-6237, we carefully analyzed the mycelial extract toˆnd a new erinacine. A reciprocally shaken culture in 2000-ml Sakaguchi ‰asks, each containing 500 ml of a medium (5z D-glucose-0.5z peptone-1z Pharmamedia-0.5z NaCl) was chose as one of the most eŠective media for producing erinacines with this basidiomycete. The EtOAc extract (6.6 g) obtained from the mycelia was separated by silica gel ‰ash chromatography with mixtures of CHCl3 and EtOH (40:1-5:1) as the eluent and gave a new erinacine named erinacine Q (1).
The molecular formula of 1 was determined as C27H42O8 from its HR-FABMS data. Its 1 H-and 13 C-NMR spectra showed similar signals to those of 2.
8)
The former diŠered from the latter by the presence of a hydroxymethyl group [d H 4.08, (2H, br. s)] instead of a formyl group. The characteristic methine proton at C-11 in 1 appeared at d 5.98 and was coupled to the methylene protons of C-10 in the H-H COSY spectrum. Its also had a correlation peak with the carbonyl carbon (d C 171.4) of the acetyl group in HMBC measument. The oleˆnic proton at d 5.87 was coupled to an oxymethine proton of C-14 at d 3.73. The stereochemistry at C-11 and C-14 was determined by difNOE experiments; clear NOEs were observed between H5 W H11 and H14 W H16. Thus, 1 has the same C-ring structure as that of 2, but without the functional group at C-15. The absolute stereostructure of 1 was unambiguously conˆrmed by the chemical transformation of 2 to 1. The speciˆc rotation of the primary alcohol derivative from 2 ("39.89 ) was good agreement with that of 1 ("43.69 ). The stereo-structure of 1 was thus elucidated to be shown in Fig. 1 .
While a trace amount of 4 was detected by the HPLC analysis, considerable amounts of 1 (ca. 150 mg W liter) and 2 (ca. 120 mg W liter) were detected 11 days after inoculating the YB4-6237 strain; the former then decreased rapidly to less than 30 mg W liter. The twenty-day culture of this strain gave large amounts of 2 and 4 (ca. 540 mg and ca. 440 mg from one liter of culture). In addition, our group has recently reported that 2 was chemically converted into 4 and then to 3 under mild chemical conditions. 8) Theseˆndings suggest that 1 was a putative biosynthetic precursor of 2 as a parental metabolite of other important erinacines.
In order to clarify the biosynthetic relationship between 1 and other erinacines in this basidiomycete, we examined the incorporation of The heights of the C-14 signals from the 13 C-labeled erinacines were each adjusted to be the same with corresponding natural 13 C isotopic abundance.
(H-1?, d 4.51). Since each absolute 13 C abundance at C-1? in addition to each intensity of the C-1? signal of [1?-13 C]-1 and [1?-13 C]-2 was su‹ciently enriched in their 13 C-NMR spectra (Figs. 2(b) and 2(e)), we used these 13 C-labeled substrates for the feeding experiments.
In view of the need to avoid any dilution of the 13 Clabeled substrate when feeding with endogenous erinacines, feeding experiments with [1?-13 C]-1 (erinacine Q) were carried out in a reciprocally shaken culture in small 100-ml Sakaguchi ‰asks containing 30 ml of a diluted 2z glucose-0.2z peptone-0.4z Pharmamedia-0.2z NaCl medium, which resulted in low production of 2-3 mg of endogenous 2 in the medium (100 ml) by an HPLC analysis. When 2 wasˆrst detected in the mycelia 10 days after inoculation, [1?-13 C]-1 was immediately added to the culture, and incubation was continued for a further 7 days. The EtOAc extract obtained from the mycelia was separated in a similar manner to that already described to yield 2. Its 13 C-NMR spectrum ( Fig. 2(c) ) showed that the C-1? position had been clearly labeled with the 13 C atom. The absolute 13 C abundance at C-1? was obtained as ca. 12z by the 1 H-NMR analysis. These observations indicate that feeding erinacine Q had been easily metabolized with the endogenous one to erinacine P in the basidiomycete.
Feeding experiments with [1?-13 C]-2 (erinacine P) were carried out in a similar manner to that used for [1?-13 C]-1. [1?-13 C]-2 was added to the culture 13 days after inoculation, and incubation was continued for a further 16 days. Throughout these 16 days, trace amounts of 3 and 4 were detected in the mycelia by an HPLC analysis, and 5 was markedly accumulated. 5 and [1?-13 C]-2 were respectively separated from the EtOAc extract which had been obtained from the mycelia. In the 13 C-NMR spectrum of 5 ( Fig. 2(f ) ), the C-1? position was clearly labeled with 13 C atom in comparison with that of non-labeled 5 ( Fig. 2(g) ). This observation indicates that erinacine P had been metabolized to erinacine C. The absolute 13 C abundance at C-1? could not estimated by 1 13 C-labeled 5, however, was not diluted at all with endogenous 5, because only a trace amount of 5 was detected by the HPLC analysis in the culture medium not containing 13 C-labeled 2.
The a, b-unsaturated aldehyde moiety would be essential for a biosynthetic precursor of erinacines B and C. Since the most likely explanation is that the Cring, which was common to erinacines B and C, would be formed by 1,4-conjugated addition to the b-position (C-13) of the a, b-unsaturated aldehyde with the 2?-hydroxy group of the xylosyl moiety, with subsequent elimination of the acetate. 8) In fact, erinacine C was biotransformed from erinacine P which had such an a, b-unsaturated aldehyde moiety. Therefore, it seems that erinacine C may be derived from erinacine P via erinacine B. A trace amount of erinacine B was detected by the HPLC analysis (tR 6.1 min), but was not su‹cient for an NMR analysis. In order to clarify the biosynthetic relationship between erinacines P and B in this basidiomycete, bioconversion experiments of [1?-13 C]-erinacine P into erinacine B by using a medium which results in a marked accumulation of erinacine B will be needed.
Feeding experiments with [1?-13 C]-erinacine Q and [1?-13 C]-erinacine P clearly demonstrated that erinacine Q was converted via erinacine P into erinacine C in Hericium erinaceum YB4-6237. Erinacines Q and P may be the common biosynthetic intermediates of cyathane xylosides in this basidiomycete, and others such as erinacines A, B, C and H in H. erinaceum, [1] [2] [3] [4] 8) erinacines E, F and G in H. romosum, 6, 10, 11) and striatals and striatins in Cyathus spp. 5, [9] [10] [11] and Gerronemaˆbula. 10, 11) The biosynthetic hydrocarbon intermediate in the early stage of erinacine biosynthesis in H. erinaceum YB4-6237 has recently been investigated by our group, and isolation and structural determination of (")-cyatha-3,12-diene and its formation from all-trans-geranylgeranyl diphosphate in a cell-free system have been reported. 12) Erinacines and the biosynthetic intermediates obtained from H. erinaceum YB4-6237 are biosynthetically arranged in Fig. 3 . 8, 12) We are now searching for putative hydroxylated-cyathadiene intermediates in the biosynthesis of erinacine aglycon from erinacine-producing H. erinaceum YB4-6237.
